TARANasdaq

Protara Therapeutics, Inc.

Biological Products, (No Diagnostic Substances) · CIK 1359931

Advancing transformative cell therapies and phospholipid substrate replacement therapies for cancer and rare diseases

red 8-K · 90d

$219M

Market cap

$3.82

Last close

-8.2%

-4.5%

2.2M

Volume

Price · last 40 sessions-29.9%

May 4L $3.65 · H $5.66Jun 30

244

Total filings

Jun 29, 2026

Last filing

12/31

Fiscal year end

Similar companies

Comparable business profile · signals at a glance